Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne
May 29, 2018 08:42 ET
|
Concerned Shareholder of Arcturus Therapeutics, Joseph Payne
SAN DIEGO, May 29, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ:ARCT) (“Arcturus” or the “Company), a leading RNA medicines company, today announced that, as part of a settlement...
Arcturus Therapeutics Founder Joseph Payne Calls for an End to Company’s Frivolous and Costly Lawsuits; Applauds Court Decision and Welcomes June 25, 2018 EGM Date
May 23, 2018 07:30 ET
|
Concerned Shareholder of Arcturus Therapeutics, Joseph Payne
Applauds court decision to require disclosure of complaint filed against Joe Payne and other Arcturus shareholders as reasonable solution to end costly securities litigation Welcomes Israeli Court...
Arcturus Therapeutics Founder Joseph Payne Welcomes Court Decision to Set Date and Agenda of Extraordinary General Meeting to Vote for New Board Members
May 14, 2018 15:05 ET
|
Concerned Shareholder of Arcturus Therapeutics, Joseph Payne
Court rules that a notification for Extraordinary General Meeting must be issued this weekThe Extraordinary General Meeting to be scheduled between June 18 and June 24, 2018Court ruling also...
Arcturus Therapeutics Founder Joseph Payne Successfully Prevents Board’s Egregious Attempt to Dilute Shareholders
May 02, 2018 09:30 ET
|
Concerned Shareholder of Arcturus Therapeutics, Joseph Payne
Israeli District Court enjoins attempt by board to dilute shareholders through sale of 24.9% of Arcturus share capitalCourt found sufficient evidence to support the claim that the members of the...
Arcturus Therapeutics Founder Joseph Payne Dismisses Board’s Baseless Lawsuit as Desperate Entrenchment Tactic
April 23, 2018 09:30 ET
|
Concerned Shareholder of Arcturus Therapeutics, Joseph Payne
Warns lawsuit is another attempt by Arcturus’ board to distract shareholders from the Company’s abhorrent governance deficienciesCalls on board to respect the rights of all shareholders and...
Arcturus Therapeutics Founder Joseph Payne Disappointed by Board’s Desperate Attempt to Delay Meeting and Avoid Shareholder Accountability
April 13, 2018 11:43 ET
|
Concerned Shareholder of Arcturus Therapeutics, Joseph Payne
Change in Arcturus board is needed on an urgent basis to improve the company’s performanceBoard’s decision to indefinitely delay inevitable change is a clear act of entrenchment Overwhelming support...